Literature DB >> 2866577

Exercise performance and beta-blockade.

P A Tesch.   

Abstract

beta-Adrenoceptor blockers (beta-blockers) are common first-choice drugs in the treatment of various cardiovascular disorders. Physical exercise performed during single-dose administration of beta-blockers, however, is associated with an increased rate of perceived exertion; an effect which appears to be partly reduced with long term treatment. Although clinical doses of beta-blockade may reduce heart rate by 30 to 35%, during maximal exercise cardiac output is not equally reduced. Accordingly, most studies have demonstrated increased stroke volume after beta-blockade. This reduction in heart rate is typically accompanied by a decreased VO2max (5 to 15%) in both patients and healthy, trained subjects. This smaller reduction in VO2max, as compared with the decrease in cardiac output, is the result of a partly compensating increased arteriovenous O2 difference. Work capacity as reflected by the ability to perform intense short term or more prolonged steady-state exercise is also impaired following beta-blockade. beta-Adrenoceptors can be subdivided into types beta 1- and beta 2. Blockers which are specific for either beta 1-receptors (beta 1-selective blockers) or both beta 1- and beta 2 receptors (non-selective blockers) differ with regard to their effect on exercise performance. Exercise performance ability, irrespective of exercise intensity and duration, is impaired to a greater extent following non-selective than beta 1-selective blockade at equal reductions in heart rate. This response stems from a decreased energy flux through glycogenolysis during non-selective blockade treatment. Individuals receiving beta-blockade medication therefore show greater adaptive response to physical conditioning during treatment with beta 1-selective than non-selective blockade probably because of greater training intensity with the former therapy. Neither psychomotor performance nor muscular strength and power is negatively affected by beta-blockade. Nevertheless, the ability to perform athletic events requiring high levels of motor control under emotional stress but not high levels of aerobic or anaerobic energy release, is probably increased during beta-blockade.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866577     DOI: 10.2165/00007256-198502060-00002

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  156 in total

1.  Effects of oral propranolol in normal subjects.

Authors:  M M LeWinter; M H Crawford; J S Karliner; R A ORourke
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

2.  Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).

Authors:  J Erikssen; E Thaulow; R Mundal; P Opstad; S Nitter-Hauge
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Glucagon and plasma catecholamines during beta-receptor blockade in exercising man.

Authors:  H Galbo; J J Holst; N J Christensen; J Hilsted
Journal:  J Appl Physiol       Date:  1976-06       Impact factor: 3.531

4.  Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension.

Authors:  P Kaiser; B Hylander; K Eliasson; L Kaijser
Journal:  Am J Cardiol       Date:  1985-04-26       Impact factor: 2.778

5.  Pharmacokinetic and pharmacodynamic studies with long-acting propranolol.

Authors:  J McAinsh; N S Baber; R Smith; J Young
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

6.  Effects of beta 1-selective and nonselective beta-adrenoceptor blockade during exercise conditioning in healthy adults.

Authors:  A A McLeod; W E Kraus; R S Williams
Journal:  Am J Cardiol       Date:  1984-06-01       Impact factor: 2.778

7.  Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.

Authors:  C L van Herwaarden; R A Binkhorst; J F Fennis; A van't Laar
Journal:  Br Heart J       Date:  1979-01

8.  Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.

Authors:  A A McLeod; J E Brown; C Kuhn; B B Kitchell; F A Sedor; R S Williams; D G Shand
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

9.  Slower Adaptation of VO2 to steady state of submaximal exercise with beta-blockade.

Authors:  R L Hughson; G A Smyth
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1983

10.  Effects of beta-adrenergic blockade on ventilation and gas exchange during exercise in humans.

Authors:  E S Petersen; B J Whipp; J A Davis; D J Huntsman; H V Brown; K Wasserman
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-05
View more
  25 in total

Review 1.  Stress management for athletes.

Authors:  B Wilks
Journal:  Sports Med       Date:  1991-05       Impact factor: 11.136

Review 2.  Metabolic factors in fatigue.

Authors:  K Sahlin
Journal:  Sports Med       Date:  1992-02       Impact factor: 11.136

Review 3.  Drugs and sport. Research findings and limitations.

Authors:  P M Clarkson; H S Thompson
Journal:  Sports Med       Date:  1997-12       Impact factor: 11.136

4.  Cognition and motor impairment correlates with exercise test performance after stroke.

Authors:  Ada Tang; Janice J Eng; Teresa S M Tsang; Andrei V Krassioukov
Journal:  Med Sci Sports Exerc       Date:  2013-04       Impact factor: 5.411

Review 5.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

6.  Reliability of peak treadmill exercise tests in mild Alzheimer disease.

Authors:  Heather S Anderson; Patricia M Kluding; Byron J Gajewski; Joseph E Donnelly; Jeffrey M Burns
Journal:  Int J Neurosci       Date:  2011-05-17       Impact factor: 2.292

Review 7.  The use of ratings of perceived exertion for exercise prescription in patients receiving beta-blocker therapy.

Authors:  R Eston; D Connolly
Journal:  Sports Med       Date:  1996-03       Impact factor: 11.136

8.  Blood lactate. Implications for training and sports performance.

Authors:  I Jacobs
Journal:  Sports Med       Date:  1986 Jan-Feb       Impact factor: 11.136

9.  Exercise Capacity Before and After Stent Placement for Coarctation of the Aorta: A Single-Center Case Series.

Authors:  Brandon D Morrical; Jason H Anderson; Nathaniel W Taggart
Journal:  Pediatr Cardiol       Date:  2017-05-18       Impact factor: 1.655

Review 10.  Calcium antagonists and exercise performance.

Authors:  W Kindermann
Journal:  Sports Med       Date:  1987 May-Jun       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.